Patient Management

2074 soru

Soru 1961Soru →

A 24-year-old woman with a history of type 1 diabetes mellitus is admitted to the intensive care unit for the management of diabetic ketoacidosis (DKA). On presentation, she has a serum glucose of 580 mg/dL580 \text{ mg/dL}, an anion gap of 24 mEq/L24 \text{ mEq/L}, and a serum potassium of 4.8 mEq/L4.8 \text{ mEq/L}. She has received an initial intravenous fluid bolus of 0.9% sodium chloride.

Arrange the following monitoring and therapeutic steps in the correct chronological sequence required for the safe resolution of her DKA and transition to maintenance therapy.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for DKA management is: 1) Initiate continuous intravenous regular insulin infusion after confirming serum potassium is ≥3.3 mEq/L\geq 3.3 \text{ mEq/L}. 2) Add 5% dextrose to the intravenous fluids when the serum glucose concentration decreases to 200 mg/dL200 \text{ mg/dL}. 3) Administer the first dose of subcutaneous long-acting insulin once the serum anion gap closes (≤12 mEq/L\leq 12 \text{ mEq/L}) and the patient is able to eat. 4) Discontinue the continuous intravenous regular insulin infusion 1 to 2 hours1 \text{ to } 2 \text{ hours} after the administration of subcutaneous insulin.
The management of DKA requires strict sequential monitoring and therapeutic adjustments. Insulin is the cornerstone of treatment but drives potassium intracellularly; therefore, serum potassium must be verified as ≥3.3 mEq/L\geq 3.3 \text{ mEq/L} prior to initiation. As insulin clears ketones, it also lowers glucose rapidly. To allow continuous insulin administration until the anion gap closes without causing hypoglycemia, 5% dextrose is added to IV fluids when glucose reaches 200 mg/dL200 \text{ mg/dL}. Once the anion gap normalizes (≤12 mEq/L\leq 12 \text{ mEq/L}), DKA has resolved, and subcutaneous insulin can be administered. Finally, a 1 to 2 hour1 \text{ to } 2 \text{ hour} overlap is mandatory before stopping the IV insulin drip to allow the subcutaneous depot to absorb and prevent rebound ketoacidosis.

Adım Adım Çözüm

1
Identify the prerequisite for initiating insulin therapy.
Potassium must be ≥3.3 mEq/L\geq 3.3 \text{ mEq/L}.
Insulin causes intracellular shifts of potassium; administering it in the presence of profound hypokalemia can cause fatal arrhythmias.
2
Determine the monitoring threshold for adjusting intravenous fluids.
Add 5% dextrose when glucose reaches 200 mg/dL200 \text{ mg/dL}.
Insulin must be continued to clear ketones and close the anion gap. Adding dextrose prevents hypoglycemia during this prolonged metabolic correction.
3
Identify the criteria for transitioning to subcutaneous insulin.
Anion gap ≤12 mEq/L\leq 12 \text{ mEq/L} and patient tolerating oral intake.
A closed anion gap indicates the resolution of ketoacidosis, making it safe to transition the patient off the intravenous insulin drip.
4
Determine the protocol for stopping the intravenous insulin infusion.
Stop the continuous infusion 1 to 2 hours1 \text{ to } 2 \text{ hours} after giving subcutaneous insulin.
Subcutaneous insulin takes time to absorb. Stopping the drip immediately without an overlap will lead to a rapid drop in circulating insulin levels and rebound DKA.

Anahtar Kavram

Monitoring and sequential treatment adjustment in diabetic ketoacidosis (DKA)
Soru 1962Soru →

An emergency physician evaluates a patient who was brought in by ambulance for severe, worsening shortness of breath.

The patient is a 52-year-old female who reports progressive chest tightness, wheezing, and a sensation of her heart racing that began early this morning. Her medical history is notable for severe persistent asthma, hypertension, and recently diagnosed hyperthyroidism for which she is awaiting endocrinology follow-up. She states that she ran out of her methimazole prescription two weeks ago. Current medications include high-dose inhaled fluticasone-salmeterol, an albuterol rescue inhaler, and oral amlodipine.

Vital signs are: Temperature 37.0°C (98.6°F), blood pressure 118/76 mmHg, pulse 148/min, respirations 26/min, and oxygen saturation 90% on room air.

Physical examination reveals a patient in visible respiratory distress using accessory muscles of respiration. Lung auscultation demonstrates diffuse, bilateral expiratory wheezing with a markedly prolonged expiratory phase.

A 12-lead electrocardiogram shows a narrow-complex, irregularly irregular tachycardia at a rate of 148/min with absent P waves. There are no ischemic ST-segment changes.

The patient is immediately placed on supplemental oxygen and started on continuous nebulized albuterol, ipratropium, and intravenous methylprednisolone. Thirty minutes later, her respiratory status improves slightly (oxygen saturation now 94%), but her heart rate remains elevated at 145/min, and she complains of ongoing uncomfortable palpitations.

Which of the following is the most appropriate pharmacologic intervention to manage her heart rate?

Cevabı ve açıklamayı göster

Cevap: Intravenous diltiazem

Cevap

Intravenous diltiazem
The patient is presenting with an acute asthma exacerbation and concurrent atrial fibrillation with rapid ventricular response (AF RVR). In a hemodynamically stable patient, pharmacologic rate control is the primary goal. Non-dihydropyridine calcium channel blockers (e.g., diltiazem, verapamil) are the preferred agents for rate control in patients with severe reactive airway disease (asthma or COPD) because they effectively slow conduction through the AV node without inducing bronchospasm.

Adım Adım Çözüm

1
Interpret the clinical presentation and diagnostic data.
The patient is experiencing an acute severe asthma exacerbation and concurrent new-onset atrial fibrillation with rapid ventricular response (AF RVR).
The physical exam shows severe bronchospasm with accessory muscle use, and the ECG describes a narrow-complex, irregularly irregular rhythm lacking P waves.
2
Assess hemodynamic stability.
The patient is hemodynamically stable with a blood pressure of 118/76 mmHg.
Stability determines the need for immediate synchronized cardioversion versus pharmacologic rate control.
3
Select the most appropriate rate-control agent while accounting for absolute contraindications associated with her comorbidities.
Intravenous diltiazem is selected as the safest and most effective intervention.
Non-dihydropyridine calcium channel blockers effectively slow AV nodal conduction without exacerbating bronchoconstriction, avoiding the critical risks associated with beta-blockers in asthma or amiodarone in unmanaged hyperthyroidism.

Anahtar Kavram

Management of atrial fibrillation with rapid ventricular response (AF RVR) requires careful consideration of comorbidities. Non-dihydropyridine calcium channel blockers (diltiazem) are the preferred rate-control agents in patients with severe reactive airway disease.
Soru 1963Soru →

Paramedics bring a 42-year-old man to the trauma bay following a high-velocity motor vehicle crash. On arrival, the patient is highly agitated and gasping for air. Physical examination demonstrates severe maxillofacial crush injuries with massive ongoing hemorrhage from the nose and mouth. Vital signs show a blood pressure of 110/70 mm Hg, heart rate of 128/min, and respiratory rate of 28/min. Oxygen saturation is 81% on a high-flow non-rebreather mask. Marked intercostal retractions and audible stridor are present. Because of the distorted anatomy and copious blood pooling in the oropharynx, an experienced physician is unable to visualize the vocal cords after two attempts at direct orotracheal intubation. Subsequent attempts to oxygenate the patient using a bag-valve-mask device are ineffective. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Surgical cricothyrotomy

Cevap

Surgical cricothyrotomy
The correct answer is surgical cricothyrotomy. This patient is presenting with an acute 'cannot intubate, cannot ventilate' emergency. He has severe maxillofacial trauma with profuse oropharyngeal bleeding and marked hypoxia that is refractory to bag-valve-mask ventilation. When standard orotracheal intubation fails and non-invasive ventilation is inadequate, a surgical airway must be rapidly established to prevent anoxic brain injury and death. Surgical cricothyrotomy is the procedure of choice in this setting because it can be performed quickly at the bedside, bypassing the upper airway obstruction and securing ventilation.

Adım Adım Çözüm

1
Identify the primary clinical emergency.
The patient has impending airway loss with severe hypoxia secondary to maxillofacial trauma, and standard non-surgical airway methods have failed.
Recognizing a 'cannot intubate, cannot ventilate' scenario establishes the immediate need for a rescue airway.
2
Evaluate the contraindications for alternative airway techniques.
Nasotracheal intubation is contraindicated due to facial crush injuries, and further oral attempts will be obscured by ongoing hemorrhage.
Selecting the correct procedure requires ruling out approaches that pose a high risk of iatrogenic injury or failure.
3
Select the most appropriate procedural intervention.
Surgical cricothyrotomy is selected as the definitive next step.
It is the most rapid and reliable method to establish an airway below the level of obstruction in an emergency.

Anahtar Kavram

In a 'cannot intubate, cannot ventilate' scenario, especially in the setting of severe maxillofacial trauma where other rescue methods are contraindicated or ineffective, immediate surgical cricothyrotomy is the intervention of choice.
Soru 1964Soru →

Match the following ambulatory patient profiles with their most critical, guideline-indicated preventive screening or immunization step.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A healthy 45-year-old male with no significant medical or family history, presenting for a wellness check after a decade without seeing a physician.
A 66-year-old male with a 30 pack-year smoking history who quit 8 years ago. He recently had a normal screening colonoscopy and a normal abdominal aortic ultrasound.
A 28-year-old gravida 1 para 0 at 28 weeks gestation. Her last tetanus toxoid-containing vaccine was administered 6 years ago.
A 58-year-old female with a body mass index of 33 kg/m² and normotension. She has no complaints and is up to date on her mammograms and colonoscopies.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The patients are successfully matched with their appropriate screening or immunization recommendations according to current age, risk factors, and USPSTF/ACIP guidelines.
Each patient requires a specific preventive intervention based on their demographic and clinical risk profile, aligning precisely with current evidence-based schedules.

Adım Adım Çözüm

1
Analyze the 45-year-old male patient.
Qualifies for initiation of colorectal cancer screening.
Current guidelines lowered the screening initiation age for colorectal cancer from 50 to 45 for average-risk individuals.
2
Analyze the 66-year-old former smoker.
Qualifies for annual LDCT.
He meets the age criteria (50-80 years), pack-year criteria (≥20 pack-years), and quit-date criteria (quit <15 years ago) for lung cancer screening.
3
Analyze the pregnant woman at 28 weeks gestation.
Needs Tdap vaccination.
Tdap is recommended in every pregnancy (optimally at 27-36 weeks) to maximize maternal antibody response and passive transfer to the fetus.
4
Analyze the 58-year-old female with a BMI of 33 kg/m².
Needs diabetes screening.
Asymptomatic adults aged 35-70 with overweight or obesity require screening for abnormal blood glucose.

Anahtar Kavram

Preventive Care and Screening Guidelines (USPSTF and ACIP)
Tahmini Süre:1m 30s
Soru 1965Soru →

During a busy morning in the primary care clinic, a physician evaluates four different adult patients for their routine health maintenance visits. For each patient presentation, identify the single most appropriate, guideline-concordant preventive screening or immunization intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 69-year-old man who reports smoking approximately five packs of cigarettes total during his college years but has completely abstained since.
A 44-year-old man who was recently diagnosed with stage 3a chronic kidney disease secondary to uncontrolled hypertension.
A 32-year-old woman presenting to establish care who has no prior documentation of any routine bloodwork or infectious disease testing.
A 56-year-old woman with a 25 pack-year smoking history who successfully and completely abstained from tobacco for the past 8 years.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The 69-year-old man requires AAA screening; the 44-year-old man with CKD requires pneumococcal vaccination; the 32-year-old woman requires one-time HIV screening; and the 56-year-old former smoker requires annual LDCT.
Each patient profile maps to a highly-tested USPSTF or ACIP preventive care guideline. The 69-year-old man meets the specific 100-cigarette threshold for AAA screening. The 44-year-old man has CKD, a qualifying comorbidity for early pneumococcal vaccination. The 32-year-old woman falls into the universal HIV screening age bracket. The 56-year-old woman meets all three criteria for lung cancer screening (age 50-80, ≥20 pack-years, quit <15 years ago).

Adım Adım Çözüm

1
Evaluate the 69-year-old man's brief smoking history against USPSTF definitions.
He meets the criteria for AAA screening.
The definition of 'ever smoked' for AAA screening is 100 lifetime cigarettes (5 packs). As a male aged 65-75 meeting this threshold, he requires one-time ultrasound screening.
2
Assess the 44-year-old man's new diagnosis of chronic kidney disease.
He requires early pneumococcal vaccination.
Chronic kidney disease places adults aged 19-64 at high risk for invasive pneumococcal disease, warranting vaccination before age 65.
3
Review the 32-year-old woman's preventive screening history.
She requires HIV screening.
Universal, one-time HIV screening is indicated for all adults between ages 15 and 65, independent of recognized risk factors.
4
Analyze the 56-year-old woman's age and timeline of smoking cessation.
She qualifies for continued LDCT screening.
She meets the age criteria (50-80), pack-year criteria (≥20), and has quit within the critical 15-year window.

Anahtar Kavram

Guideline-based application of USPSTF and ACIP preventive screening and immunization recommendations tailored to patient age, discrete risk factors, and specific comorbidities.
Soru 1966Soru →

A 35-year-old man is brought to the emergency department by emergency medical services following a high-speed motorcycle collision. On arrival, he is confused and diaphoretic. His temperature is 36.5°C (97.7°F), blood pressure is 78/45 mm Hg, pulse is 135/min, and respiratory rate is 28/min. Pulse oximetry shows 88% on room air. Primary survey reveals a patent airway but absent breath sounds over the right hemithorax and dullness to percussion. An extended focused assessment with sonography in trauma (eFAST) scan reveals a large fluid collection in the right pleural space and no pericardial effusion. A right-sided tube thoracostomy is promptly placed, which immediately drains 1,600 mL of bright red blood. The patient's blood pressure transiently improves to 88/50 mm Hg after the administration of 1 liter of intravenous crystalloid fluid, but then drops back to 76/40 mm Hg. Which of the following are the most appropriate immediate next steps in the management of this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Transfer to the operating room for an urgent exploratory thoracotomy; Activation of a massive transfusion protocol

Cevap

The most appropriate immediate next steps are transferring the patient to the operating room for an urgent exploratory thoracotomy and activating a massive transfusion protocol.
This patient has a massive hemothorax, evidenced by the immediate drainage of 1,600 mL of blood upon tube thoracostomy placement. The standard indications for an urgent exploratory thoracotomy in the setting of a hemothorax include an immediate initial output of greater than 1,500 mL (or 20 mL/kg), continuous bleeding at a rate of greater than 200 mL/hr for 2 to 4 consecutive hours, or persistent hemodynamic instability despite adequate resuscitation. Since this patient meets the absolute criteria for a thoracotomy, he must be transferred immediately to the operating room. Simultaneously, because he is in severe hemorrhagic shock that has not responded to initial crystalloid resuscitation, activation of a massive transfusion protocol is required to provide packed red blood cells, fresh frozen plasma, and platelets, typically in a 1:1:1 ratio, to prevent the lethal triad of trauma (coagulopathy, hypothermia, and acidosis).

Adım Adım Çözüm

1
Assess the patient's hemodynamic status and response to initial interventions.
The patient remains in refractory hemorrhagic shock (blood pressure 76/40 mm Hg) despite initial fluid resuscitation and chest tube placement.
Determining hemodynamic stability is the primary branch point in trauma management algorithms.
2
Evaluate the output from the tube thoracostomy.
The chest tube immediately drained 1,600 mL of bright red blood.
Massive hemothorax is defined by an immediate output of >1,500 mL, which is a universally accepted indication for urgent surgical intervention.
3
Determine the definitive management and resuscitation strategy.
The patient requires surgical control of bleeding (thoracotomy) and balanced blood product resuscitation (massive transfusion protocol).
Crystalloid alone is insufficient for massive hemorrhage and causes dilutional coagulopathy, necessitating a 1:1:1 transfusion strategy concurrent with surgical repair.

Anahtar Kavram

In patients with a massive hemothorax (defined as >1,500 mL of immediate chest tube output or >200 mL/hr for 2-4 hours), the most appropriate management is urgent exploratory thoracotomy accompanied by activation of a massive transfusion protocol.
Soru 1967Soru →

A 22-year-old woman is brought to the emergency department by her roommate due to progressive lethargy, confusion, and recurrent vomiting over the last 48 hours. The patient has a history of bipolar I disorder and generalized tonic-clonic seizures. Her home medications include valproic acid, which was initiated six weeks ago, and a daily multivitamin. She does not use alcohol, tobacco, or illicit drugs.

On presentation, her temperature is 36.8°C (98.2°F), blood pressure is 118/74 mm Hg, pulse is 88/min, and respiratory rate is 14/min. Physical examination shows a somnolent woman who is oriented only to her name. A bilateral flapping tremor of the hands is elicited upon wrist extension. No jaundice, scleral icterus, or abdominal distension is noted.

Laboratory studies are obtained:

TestResultReference Range
Sodium139 mEq/L136-145 mEq/L
Potassium4.1 mEq/L3.5-5.0 mEq/L
Blood urea nitrogen12 mg/dL8-20 mg/dL
Creatinine0.8 mg/dL0.6-1.2 mg/dL
Aspartate aminotransferase (AST)28 U/L10-40 U/L
Alanine aminotransferase (ALT)30 U/L7-56 U/L
Total bilirubin0.7 mg/dL0.1-1.2 mg/dL
Alkaline phosphatase75 U/L44-147 U/L
Valproic acid level82 µg/mL50-125 µg/mL
Venous ammonia180 µmol/L15-45 µmol/L

Which of the following is the most appropriate next step in the management of this patient's current condition?

Cevabı ve açıklamayı göster

Cevap: Discontinue valproic acid and administer intravenous levocarnitine

Cevap

Discontinue valproic acid and administer intravenous levocarnitine
The correct answer is to discontinue valproic acid and administer intravenous levocarnitine. This patient presents with altered mental status, asterixis, and significantly elevated venous ammonia in the context of recent valproic acid initiation. Notably, her liver function tests (AST, ALT, bilirubin) and her serum valproic acid level are entirely within normal reference limits. This presentation is classic for valproic acid-induced hyperammonemic encephalopathy (VHE). VHE is characterized by elevated ammonia levels leading to encephalopathy without evidence of hepatocellular injury or frank drug overdose. Valproic acid metabolism consumes carnitine, and its toxic metabolites inhibit carbamoyl phosphate synthetase I, a critical, rate-limiting enzyme in the urea cycle. This inhibition leads to the rapid accumulation of ammonia. The definitive management of VHE involves the immediate cessation of the offending agent (valproic acid) and the administration of levocarnitine (L-carnitine). Levocarnitine replenishes systemic carnitine stores, binds to toxic valproic acid metabolites to facilitate their renal excretion, and effectively restores normal urea cycle function.

Adım Adım Çözüm

1
Interpret the clinical presentation and laboratory findings.
The patient has altered mental status, asterixis, and hyperammonemia, with completely normal liver function tests and a therapeutic valproic acid level.
This specific constellation points to a metabolic encephalopathy rather than primary hepatocellular failure.
2
Identify the underlying pharmacological syndrome.
The clinical picture is diagnostic for valproic acid-induced hyperammonemic encephalopathy (VHE).
Valproic acid can disrupt the urea cycle and cause severe hyperammonemia without concurrent liver injury, often occurring even when serum drug levels are within the normal therapeutic range.
3
Determine the targeted treatment for this condition.
The correct intervention is immediate discontinuation of valproic acid and administration of levocarnitine.
Levocarnitine replenishes the carnitine stores that are depleted by valproic acid metabolism, thereby rescuing the urea cycle and enabling the excretion of ammonia.

Anahtar Kavram

Valproic acid-induced hyperammonemic encephalopathy can occur despite normal liver function tests and therapeutic serum drug levels; the definitive treatment is immediate discontinuation of the drug and administration of levocarnitine.
Tahmini Süre:1m 30s
Soru 1968Soru →

A 24-year-old man comes to the emergency department due to sudden-onset severe dyspnea, palpitations, and lightheadedness that began while playing basketball. He reports no chest pain but feels as though he might pass out. His medical history is significant for a heart murmur identified during adolescence, though he was lost to follow-up. Vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 92/60 mmHg92/60\text{ mmHg}, pulse 132/min132\text{/min} and regular, and respirations 24/min24\text{/min}. Pulse oximetry is 91%91\% on room air. Physical examination reveals a harsh, crescendo-decrescendo systolic murmur at the left lower sternal border; the murmur's intensity increases when the patient transitions from a squatting to a standing position. Pulmonary auscultation reveals fine crackles at both lung bases. An electrocardiogram demonstrates sinus tachycardia with marked left ventricular hypertrophy and deep, narrow Q waves in the lateral leads. Which of the following is the most appropriate initial pharmacologic intervention?

Cevabı ve açıklamayı göster

Cevap: Intravenous metoprolol

Cevap

Intravenous metoprolol
The correct intervention is a beta-blocker (intravenous metoprolol). This patient is experiencing acute cardiovascular compromise secondary to hypertrophic obstructive cardiomyopathy (HOCM), characterized by a dynamic left ventricular outflow tract (LVOT) obstruction. The obstruction occurs when the anterior leaflet of the mitral valve is pulled toward the hypertrophied interventricular septum during systole (systolic anterior motion, or SAM). Exertion-induced tachycardia limits diastolic filling time, resulting in a smaller end-diastolic volume. A smaller ventricular cavity brings the mitral valve and septum closer together, acutely worsening the obstruction, dropping cardiac output, and causing backward failure (pulmonary crackles). Intravenous beta-blockers slow the heart rate (allowing more time for ventricular filling) and decrease myocardial contractility (reducing the flow velocity that triggers the Venturi effect on the mitral valve). Together, these actions increase ventricular volume, relieve the LVOT obstruction, and improve forward cardiac output.

Adım Adım Çözüm

1
Analyze the patient's presentation and physical exam findings.
The young patient has exertional presyncope, a murmur that increases with standing (decreased preload), and ECG findings of LVH. This is diagnostic of hypertrophic obstructive cardiomyopathy (HOCM).
Accurate diagnosis is required to understand the mechanism behind the patient's acute pulmonary edema (bibasilar crackles) and hypotension.
2
Determine the pathophysiological mechanism of the acute decompensation.
Tachycardia (from exertion) reduced diastolic filling time, lowering the left ventricular end-diastolic volume (LVEDV). This smaller cavity size brought the anterior leaflet of the mitral valve closer to the hypertrophied septum, worsening the dynamic left ventricular outflow tract (LVOT) obstruction via systolic anterior motion (SAM).
Identifying that the pulmonary edema is driven by severe diastolic dysfunction and dynamic obstruction, rather than systolic failure, dictates the treatment approach.
3
Select the appropriate pharmacologic intervention.
A negative chronotrope and negative inotrope (intravenous metoprolol) is required to slow the heart rate, increase LVEDV, and reduce the force of contraction, which will alleviate the LVOT obstruction and subsequently resolve the pulmonary edema.
Unlike standard systolic heart failure, treating HOCM with preload reducers (diuretics, nitrates) or inotropes is absolutely contraindicated and will worsen the shock state.

Anahtar Kavram

In patients with hypertrophic obstructive cardiomyopathy (HOCM) presenting with acute dynamic outflow obstruction and pulmonary edema, negative inotropes/chronotropes (e.g., beta-blockers) are indicated to increase ventricular volume and relieve the obstruction; preload-reducing and afterload-reducing agents are contraindicated.

Alternatif Yöntem

In patients who do not tolerate beta-blockers or when beta-blockers are contraindicated (e.g., severe reactive airway disease), non-dihydropyridine calcium channel blockers (such as intravenous verapamil or diltiazem) are the appropriate alternative negative inotropes/chronotropes to relieve the obstruction.
Tahmini Süre:1m 30s
Soru 1969Soru →

A 72-year-old man is evaluated in the primary care clinic to discuss stroke prevention. He was recently diagnosed with nonvalvular atrial fibrillation after presenting with intermittent palpitations. He has a history of hypertension, benign prostatic hyperplasia, and osteoarthritis. Current medications include lisinopril, tamsulosin, and acetaminophen as needed. His heart rate is currently 78/min and regular. After a shared decision-making discussion regarding his CHA2DS2-VASc score and bleeding risks, the physician decides to initiate rivaroxaban.

Which of the following laboratory evaluations are essential for baseline assessment and routine ongoing monitoring of this specific pharmacotherapy? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Serum creatinine to estimate creatinine clearance; Complete blood count

Cevap

The essential parameters for routine monitoring of rivaroxaban therapy are serum creatinine (to estimate creatinine clearance) and a complete blood count.
Rivaroxaban is a direct factor Xa inhibitor. Because it is partially cleared by the kidneys, patients must have their serum creatinine and calculated creatinine clearance evaluated at baseline and periodically (at least annually) to detect renal decline, which would necessitate dose adjustment or discontinuation to prevent bleeding. Additionally, a baseline and periodic complete blood count is essential to monitor for anemia secondary to occult gastrointestinal or genitourinary bleeding, a known risk of any anticoagulant.

Adım Adım Çözüm

1
Identify the initiated pharmacotherapy and its mechanism of action.
The patient is starting rivaroxaban, which is a direct oral anticoagulant (DOAC) that inhibits factor Xa.
Understanding the drug class is necessary to determine appropriate monitoring parameters and distinguish them from older anticoagulants.
2
Determine the baseline and ongoing monitoring requirements for DOACs.
DOACs require baseline and periodic assessment of renal function (creatinine clearance) and a complete blood count. Liver function tests are also typically checked at baseline.
DOACs undergo renal clearance, meaning declining kidney function can lead to drug accumulation and increased bleeding risk. A CBC helps monitor for occult bleeding.
3
Evaluate the need for routine coagulation monitoring.
Unlike warfarin or unfractionated heparin, DOACs have predictable pharmacokinetics and do not require routine therapeutic drug monitoring with INR, aPTT, or anti-factor Xa assays.
Routine coagulation testing does not improve safety or efficacy for patients on DOACs and can lead to unnecessary clinical interventions.

Anahtar Kavram

Monitoring parameters for Direct Oral Anticoagulants (DOACs)
Soru 1970Soru →

A dermatologist refers a 58-year-old woman to the primary care clinic to optimize her preventive health measures. She has a 10-year history of severe plaque psoriasis that is currently well controlled with adalimumab monotherapy. She has no other medical conditions and does not use tobacco or alcohol. Her surgical history is notable for an uncomplicated appendectomy in her twenties. She reports having a painful episode of shingles on her right flank three years ago. Review of her records shows that a screening mammogram and a co-testing cervical cancer screening (Pap smear and HPV testing) were both performed one year ago with normal results. Her last screening colonoscopy was at age 50 and was entirely normal. Her immunizations are up to date for annual influenza, and a tetanus-diphtheria-acellular pertussis (Tdap) booster was given four years ago. She has not received any pneumococcal or zoster vaccinations. Which of the following is the most appropriate next step in this patient's preventive management?

Cevabı ve açıklamayı göster

Cevap: Administer the recombinant zoster vaccine

Cevap

Administer the recombinant zoster vaccine
The recombinant zoster vaccine is an inactivated vaccine recommended for all adults aged 50 years and older to prevent herpes zoster and postherpetic neuralgia. It is also explicitly recommended for adults aged 19 years and older who are immunosuppressed due to disease or therapy, such as those taking tumor necrosis factor (TNF) inhibitors like adalimumab. A prior episode of herpes zoster is not a contraindication; vaccination is still indicated to prevent future recurrences. Because the recombinant vaccine is not live, it is safe to administer to immunosuppressed patients without altering or holding their current medication regimen.

Adım Adım Çözüm

1
Analyze the patient's demographic and clinical profile
The patient is a 58-year-old female taking adalimumab (a tumor necrosis factor inhibitor) for psoriasis, rendering her pharmacologically immunosuppressed.
Age and immune status dictate specific screening and vaccination requirements.
2
Evaluate her preventive care history
Mammogram and Pap/HPV were normal 1 year ago (up to date). Colonoscopy was normal at age 50 (due at age 60). She lacks pneumococcal and zoster vaccines.
Identifies gaps in preventive care that need to be addressed at the current visit.
3
Determine appropriate vaccine interventions for an immunosuppressed adult
She requires both pneumococcal and zoster vaccinations. However, the correct initial pneumococcal vaccine must be a conjugate vaccine (PCV20 or PCV15), not the polysaccharide one (PPSV23).
Vaccine sequencing guidelines strictly mandate a conjugate vaccine first for vaccine-naive individuals.
4
Apply zoster vaccine guidelines considering her medication and history
The recombinant zoster vaccine is indicated. Because it is inactivated, it can be safely given concurrently with adalimumab. Her prior episode of shingles does not preclude vaccination.
Guidelines recommend vaccination to prevent recurrent episodes, and inactivated vaccines do not require holding biologic therapies.

Anahtar Kavram

Adult immunization schedules and contraindications in immunosuppressed patients
Tahmini Süre:1m 30s
Soru 1971Soru →

A 6868-year-old woman presents to the cardiology clinic for a routine follow-up. She has a history of heart failure with reduced ejection fraction (left ventricular ejection fraction of 30%30\%). Her current daily medication regimen includes lisinopril, carvedilol, spironolactone, and digoxin. She has been stable on these medications for the past two years, with her most recent serum digoxin concentration measuring 0.8 ng/mL0.8 \text{ ng/mL} (therapeutic range for heart failure: 0.5−0.9 ng/mL0.5 - 0.9 \text{ ng/mL}). During today's visit, an electrocardiogram reveals new-onset paroxysmal atrial fibrillation with a ventricular rate of 110/min110/\text{min}. The physician decides to initiate amiodarone therapy for rhythm control and suppression of the atrial fibrillation. Which of the following is the most appropriate next step regarding her current medication regimen?

Cevabı ve açıklamayı göster

Cevap: Reduce the digoxin dosage by 50%50\% and recheck the serum digoxin concentration in 11 to 22 weeks

Cevap

Reduce the digoxin dosage by 50%50\% and recheck the serum digoxin concentration in 11 to 22 weeks
Amiodarone is a potent inhibitor of P-glycoprotein, which is the primary efflux transporter responsible for the renal and biliary clearance of digoxin. When amiodarone is initiated in a patient already taking digoxin, the clearance of digoxin decreases significantly, causing serum concentrations to rise by approximately 70%70\% to 100%100\%. To prevent severe and potentially fatal digoxin toxicity (e.g., life-threatening arrhythmias, visual disturbances, nausea), the standard of care requires preemptively reducing the digoxin dose by 30%30\% to 50%50\% when amiodarone is started. Close clinical monitoring and a repeat serum digoxin level should be evaluated within 11 to 22 weeks after the adjustment.

Adım Adım Çözüm

1
Identify the critical drug-drug interaction between the newly prescribed amiodarone and the patient's baseline digoxin.
Amiodarone inhibits P-glycoprotein, reducing the clearance of digoxin and significantly elevating its serum levels.
Recognizing pharmacokinetic interactions is a mandatory safety check prior to finalizing treatment modifications.
2
Determine the appropriate dose adjustment and monitoring interval for digoxin.
The digoxin dose must be empirically reduced by 30%30\% to 50%50\%, followed by a repeat serum level check in 11 to 22 weeks.
Preemptive dose reduction prevents life-threatening digoxin toxicity, such as fatal arrhythmias, while maintaining therapeutic efficacy.

Anahtar Kavram

When initiating amiodarone in a patient currently taking digoxin, the digoxin dose must be reduced by 50%50\% to prevent toxicity due to amiodarone's inhibition of P-glycoprotein-mediated digoxin clearance.
Tahmini Süre:1m 15s
Soru 1972Soru →

A 45-year-old man with a history of poorly controlled type 2 diabetes mellitus presents to the emergency department with a 24-hour history of severe left knee pain, swelling, and subjective fevers. He reports no recent trauma to the area. Vital signs show a temperature of 39.1°C (102.4°F), blood pressure of 110/70 mm Hg, heart rate of 112/min, and respiratory rate of 18/min. On physical examination, the left knee is markedly swollen, erythematous, and warm to the touch. Severe pain is elicited with minimal passive range of motion, and the patient refuses to bear weight on the affected limb. Arrange the following surgical and medical management steps in the most appropriate chronological order for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first perform a diagnostic arthrocentesis, followed by the administration of empiric intravenous antibiotics, then transfer for urgent surgical irrigation and debridement, and finally transition to targeted antimicrobial therapy.
The management of acute native joint septic arthritis dictates a strict procedural and medical sequence to maximize joint preservation and patient survival. Diagnostic arthrocentesis must be the initial step to secure microbiological data. This is immediately followed by empiric intravenous antibiotics to halt infection spread. Crucially, septic arthritis requires urgent surgical or procedural intervention (arthroscopic or open irrigation and debridement) because antibiotics alone cannot adequately penetrate and clear the thick, enzymatic purulence trapped within the articular capsule. Finally, therapy is narrowed based on definitive culture results.

Adım Adım Çözüm

1
Perform diagnostic arthrocentesis.
Obtains synovial fluid for cell count, Gram stain, and culture.
Securing a microbiological sample must precede antibiotic administration to prevent sterilizing the culture and losing the ability to identify the precise pathogen.
2
Initiate empiric intravenous antibiotics.
Provides immediate systemic antimicrobial coverage.
Rapidly controls the spread of infection and begins arresting local tissue destruction while awaiting definitive surgical management.
3
Perform urgent arthroscopic irrigation and debridement.
Mechanically clears purulence, debris, and inflammatory cytokines from the joint space.
Achieves definitive procedural source control, which is mandatory in septic arthritis to prevent irreversible cartilage necrosis.
4
De-escalate to targeted antimicrobial therapy.
Narrows the antibiotic spectrum to specifically treat the isolated organism.
Optimizes long-term efficacy, minimizes toxicity, and reduces the risk of antimicrobial resistance.

Anahtar Kavram

Chronological procedural management of acute septic arthritis
Soru 1973Soru →

A 7272-year-old man with a history of small cell lung cancer is brought to the emergency department after a witnessed generalized tonic-clonic seizure. His family reports that he has been progressively confused and lethargic over the past 33 days. On arrival, he is postictal but protecting his airway. His vital signs are within normal limits. Laboratory studies reveal:

* Serum sodium: 112112 mEq/L
* Serum potassium: 4.04.0 mEq/L
* Serum osmolality: 240240 mOsm/kg
* Urine osmolality: 600600 mOsm/kg
* Urine sodium: 5050 mEq/L

Arrange the following steps in the correct chronological sequence for the acute management and ongoing monitoring of this patient's condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence begins with the immediate administration of a hypertonic saline bolus to treat the active seizure, followed by a clinical reassessment to determine if a repeat bolus is needed. Once stabilized, serum sodium is monitored every 22 hours to ensure safe correction rates, and hypertonic saline is discontinued as soon as the sodium rises by 44 to 66 mEq/L. Finally, long-term management with fluid restriction is initiated.
This sequence represents the standard of care for severe symptomatic hyponatremia. The first step is to administer 3%3\% hypertonic saline to acutely raise the serum sodium and reduce cerebral edema. If severe symptoms like seizures persist, the bolus should be repeated immediately. Once the patient is stabilized, serum sodium must be monitored frequently (typically every 22 hours) to evaluate the treatment response and ensure the correction rate does not exceed safe limits. Hypertonic saline must be discontinued once symptoms resolve or the sodium level has risen by 44 to 66 mEq/L, as this is sufficient to reverse life-threatening cerebral edema. Finally, the underlying cause (SIADH due to small cell lung cancer) is managed long-term with fluid restriction and targeted cancer therapy.

Adım Adım Çözüm

1
Immediate Intervention
Administer a rapid bolus of 3%3\% hypertonic saline.
To acutely reduce cerebral edema and halt the seizure activity in a patient with severe, symptomatic hyponatremia.
2
Clinical Reassessment
Repeat the hypertonic saline bolus if seizures continue.
Persistent severe neurological symptoms indicate that the cerebral edema has not been adequately reversed.
3
Close Monitoring
Check serum sodium levels every 22 hours.
To ensure the rate of correction does not exceed the safe limit of 88 mEq/L per 2424 hours, which prevents osmotic demyelination syndrome.
4
Therapy De-escalation
Stop hypertonic saline once sodium rises by 44 to 66 mEq/L.
A 44 to 66 mEq/L rise is generally sufficient to resolve acute cerebral edema; continuing beyond this target drastically increases the risk of overcorrection.
5
Long-term Management
Start fluid restriction and treat the lung cancer.
Addresses the underlying cause, which in this case is the syndrome of inappropriate antidiuretic hormone secretion (SIADH) secondary to small cell lung cancer.

Anahtar Kavram

The management of severe symptomatic hyponatremia requires immediate hypertonic saline to raise serum sodium by 44 to 66 mEq/L to arrest seizures, followed by frequent serial monitoring (every 22 hours) to prevent overcorrection and osmotic demyelination syndrome.
Soru 1974Soru →

A 48-year-old woman comes to the clinic reporting persistently low mood, anhedonia, fatigue, and difficulty concentrating for the past three months. She states she has been struggling emotionally since completing local radiation therapy for early-stage, estrogen receptor-positive breast cancer six months ago. She has been taking tamoxifen daily since that time. In addition to her mood symptoms, she complains of severe, frequent hot flashes that wake her up multiple times a night, resulting in significant daytime sleepiness. Her vital signs are temperature 37.0°C (98.6°F), blood pressure 122/78 mm Hg, and pulse 74/min. Physical examination is unremarkable. The physician diagnoses her with major depressive disorder and discusses treatment options to manage her current symptoms. Which of the following is the most appropriate pharmacologic intervention?

Cevabı ve açıklamayı göster

Cevap: Venlafaxine

Cevap

The most appropriate pharmacologic intervention is venlafaxine, as it treats both depression and hot flashes without inhibiting the CYP2D6-mediated activation of tamoxifen.
Venlafaxine is the most appropriate pharmacologic intervention because it effectively treats both major depressive disorder and vasomotor symptoms (hot flashes) without significantly interfering with the metabolism of tamoxifen. Tamoxifen is a prodrug that must be converted to its active metabolite, endoxifen, primarily by the hepatic cytochrome P450 2D6 (CYP2D6) enzyme. Unlike many other antidepressants, venlafaxine is only a weak inhibitor of CYP2D6, allowing tamoxifen to retain its antineoplastic efficacy.

Adım Adım Çözüm

1
Analyze the patient's presenting symptoms and medical history.
The patient has new-onset major depressive disorder and severe vasomotor symptoms (hot flashes), alongside a history of ER-positive breast cancer currently managed with tamoxifen.
Establishing all active clinical issues ensures that the chosen intervention addresses both symptom clusters safely.
2
Evaluate the pharmacokinetic properties of the patient's current medications.
Tamoxifen is a prodrug that requires activation into its potent metabolite, endoxifen, by the hepatic cytochrome P450 enzyme CYP2D6.
Understanding the metabolism of current medications is crucial for preventing adverse drug-drug interactions that could compromise cancer treatment.
3
Assess the pharmacological profiles of the available treatment options for depression and hot flashes.
Paroxetine, fluoxetine, and bupropion are potent CYP2D6 inhibitors. Venlafaxine is a weak inhibitor that effectively treats both depression and hot flashes.
Strong CYP2D6 inhibitors prevent the formation of endoxifen, decreasing tamoxifen's efficacy and increasing the risk of breast cancer recurrence.
4
Select the optimal pharmacologic intervention.
Venlafaxine is selected as the safest and most effective therapy.
It successfully treats both the psychiatric and vasomotor symptoms without compromising the antineoplastic effects of tamoxifen.

Anahtar Kavram

In patients taking tamoxifen for breast cancer, strong CYP2D6 inhibitors (such as paroxetine, fluoxetine, and bupropion) must be avoided to prevent therapeutic failure; SNRIs with minimal CYP2D6 inhibition, like venlafaxine, are the preferred treatment for concurrent depression and hot flashes.
Tahmini Süre:1m 15s
Soru 1975Soru →

A 56-year-old woman comes to the clinic for a routine wellness examination. She feels well and has no specific concerns today. Her past medical history is notable for hypertension, which is well controlled with lisinopril. She has never smoked cigarettes, consumes alcohol occasionally, and exercises three times a week. Her family history is negative for cancer or osteoporotic fractures.

A review of her electronic medical record reveals the following recent screening results:
- Screening mammography performed 12 months ago showed no evidence of malignancy (BI-RADS category 1).
- Fecal immunochemical test (FIT) performed 12 months ago was negative.
- Cervical cytology with high-risk human papillomavirus (hrHPV) co-testing performed 3 years ago was negative for intraepithelial lesion or malignancy and negative for hrHPV.
- Fasting lipid panel and hemoglobin A1c performed 6 months ago were within normal limits.

She is up to date on all recommended vaccinations. Her body mass index is 24 kg/m².

Which of the following is the most appropriate next step in preventive screening for this patient?

Cevabı ve açıklamayı göster

Cevap: Fecal immunochemical test

Cevap

The most appropriate next step is to perform a fecal immunochemical test (FIT).
The correct answer is to perform a fecal immunochemical test (FIT). For average-risk adults aged 45 to 75 years, the United States Preventive Services Task Force (USPSTF) recommends routine colorectal cancer screening. There are multiple acceptable screening modalities, but they operate on different required intervals. Acceptable strategies include an annual fecal immunochemical test (FIT), an annual high-sensitivity guaiac fecal occult blood test (hsgFOBT), a multitarget stool DNA test every 1 to 3 years, a flexible sigmoidoscopy every 5 years, or a colonoscopy every 10 years. Because this patient's last FIT was exactly 12 months ago, she is due for her annual repeat screening today to maintain adequate sensitivity for detecting occult malignancy.

Adım Adım Çözüm

1
Evaluate the patient's baseline demographics and risk factors.
The patient is a 56-year-old female at average risk for most malignancies, with no smoking history and no significant family history of cancer.
Age, sex, and risk factors determine which United States Preventive Services Task Force (USPSTF) guidelines apply.
2
Assess colorectal cancer screening status.
Her last FIT was performed 12 months ago. USPSTF guidelines recommend colorectal cancer screening for adults aged 45 to 75. If FIT is the chosen modality, it must be performed annually.
To determine if repeat colorectal screening is indicated today.
3
Assess breast and cervical cancer screening status.
Her last mammogram was 12 months ago; USPSTF recommends biennial (every 2 years) screening, so she is not due. Her last cervical co-testing was 3 years ago; guidelines recommend every 5 years, so she is not due.
To rule out the need for other routine screenings.
4
Assess indications for osteoporosis and lung cancer screening.
She is under 65 with no fracture risk factors, so a DEXA scan is not indicated. She has never smoked, so low-dose chest CT is not indicated.
To avoid inappropriate overutilization of imaging modalities.

Anahtar Kavram

The recommended interval for colorectal cancer screening using the fecal immunochemical test (FIT) is annually. In contrast, standard-risk screening mammography is recommended biennially, and cervical cancer co-testing is recommended every 5 years.
Tahmini Süre:1m 15s
Soru 1976Soru →

A 61-year-old male is currently in the medical intensive care unit undergoing treatment for a severe exacerbation of chronic obstructive pulmonary disease. He was placed on prophylactic subcutaneous unfractionated heparin upon admission. On day 6 of hospitalization, routine complete blood count reveals a platelet count of 85,000/μL85,000/\mu L, a significant decline from his admission baseline of 210,000/μL210,000/\mu L. Concurrently, he complains of new-onset right calf pain, and venous duplex ultrasonography confirms a new deep vein thrombosis. A presumptive diagnosis of heparin-induced thrombocytopenia (HIT) with thrombosis is made.

Arrange the following steps for the immediate management, subsequent monitoring, and treatment evaluation of this patient in the correct chronological sequence.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence requires immediately stopping heparin, initiating a non-heparin anticoagulant, monitoring for platelet recovery, transitioning to warfarin only after platelets normalize, and discontinuing the non-heparin agent only after adequate therapeutic overlap.
The gold standard management for heparin-induced thrombocytopenia follows a strict sequence: (1) stop all heparin to halt the immune trigger, (2) provide immediate alternative systemic anticoagulation (e.g., a direct thrombin inhibitor) to manage the existing thrombosis and high prothrombotic state, (3) monitor platelets serially until they indicate the acute state is resolving (recovery to baseline or ≥150,000/μL\geq 150,000/\mu L), (4) safely introduce warfarin only when the hypercoagulable acute phase is over, and (5) ensure an adequate overlap period until the INR is completely therapeutic to avoid warfarin-induced skin necrosis.

Adım Adım Çözüm

1
Discontinue all heparin.
Halts the formation of the underlying autoantibodies against platelet factor 4 (PF4)-heparin complexes.
Continuing heparin worsens the profound prothrombotic state inherent in HIT.
2
Initiate a non-heparin anticoagulant like argatroban or bivalirudin.
Provides immediate therapeutic anticoagulation.
The patient has an active deep vein thrombosis and a high risk of systemic embolization; stopping heparin without an alternative leaves them unprotected.
3
Monitor daily platelet counts.
Establishes a timeline for resolution of the acute immune response.
The active, hypercoagulable phase of HIT is marked by thrombocytopenia. Platelet count recovery (to ≥150,000/μL\geq 150,000/\mu L) is the primary indicator that the initial massive thrombin generation has subsided.
4
Initiate warfarin at a low dose.
Begins the transition to long-term oral anticoagulation.
Warfarin must never be started while platelets are low. Warfarin causes a rapid drop in natural anticoagulant Protein C before it suppresses procoagulant factors, posing a severe risk of venous limb gangrene in active HIT.
5
Discontinue the direct thrombin inhibitor.
Completes the transition to monotherapy.
The direct thrombin inhibitor must overlap with warfarin for at least 5 days and until the INR is within the therapeutic range for 2 consecutive days, ensuring full suppression of vitamin K-dependent clotting factors.

Anahtar Kavram

Management and monitoring sequence of Heparin-Induced Thrombocytopenia (HIT)
Soru 1977Soru →

A 71-year-old man arrives at the emergency department complaining of sudden, agonizing pain in his left leg that started 3 hours ago. He has a medical history of essential hypertension and paroxysmal atrial fibrillation, but he stopped taking his prescribed apixaban two months ago. Vital signs are temperature 37.1°C (98.8°F), blood pressure 148/88 mm Hg, heart rate 118/min and irregularly irregular, and respiratory rate 18/min. On physical examination, the left lower extremity is pale, mottled, and cold to the touch from the mid-thigh distally. The patient reports severe numbness over the dorsal aspect of his left foot and demonstrates mild weakness when asked to actively dorsiflex his toes. Handheld Doppler ultrasound evaluation of the left lower extremity reveals absent arterial signals in the dorsalis pedis and posterior tibial arteries, but venous signals remain audible.

Which of the following are the most appropriate immediate next steps in the management of this patient? (Select exactly 2 options)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Administration of an intravenous bolus of unfractionated heparin; Emergent consultation for open surgical embolectomy

Cevap

The most appropriate immediate next steps are the administration of an intravenous bolus of unfractionated heparin and an emergent consultation for open surgical embolectomy.
This patient presents with acute limb ischemia, likely secondary to a thromboembolus originating from his heart due to medication-noncompliant atrial fibrillation. The severity of acute limb ischemia is staged using the Rutherford classification. This patient exhibits sensory loss (numbness over the dorsum of the foot), mild motor weakness (weak toe dorsiflexion), absent arterial Doppler signals, and preserved venous Doppler signals. This specific constellation of physical findings categorizes his leg as an immediately threatened limb (Rutherford category IIb). The management of a category IIb limb requires a two-pronged immediate approach: halting thrombus progression and urgently restoring blood flow. An intravenous bolus of unfractionated heparin provides immediate systemic anticoagulation to prevent the clot from extending into the distal microcirculation. Concurrently, emergent open surgical revascularization (such as a transfemoral embolectomy) is required because it is the fastest method to restore arterial inflow and salvage the limb before irreversible neuromuscular necrosis occurs.

Adım Adım Çözüm

1
Evaluate the severity of the acute limb ischemia based on the physical examination and Doppler findings.
The patient has sensory loss, mild motor weakness, absent arterial Doppler signals, and audible venous signals, which classifies his condition as a Rutherford category IIb (immediately threatened) limb.
Categorizing the ischemia determines whether the patient has time for imaging/medical therapy or requires emergent surgical intervention.
2
Determine the necessary initial medical stabilization.
Systemic anticoagulation with intravenous unfractionated heparin should be administered immediately.
Heparin prevents further propagation of the existing thrombus and protects the distal collateral microcirculation while awaiting surgery.
3
Select the appropriate definitive interventional strategy.
Emergent open surgical revascularization (embolectomy) must be consulted for immediately.
A category IIb limb has a very narrow window before irreversible neuromuscular necrosis occurs; open surgery restores perfusion much faster than pharmacological thrombolysis.

Anahtar Kavram

Management of acute limb ischemia is dictated by the Rutherford classification. An immediately threatened limb (category IIb) characterized by resting pain, motor weakness, sensory loss, and inaudible arterial Doppler signals requires immediate systemic anticoagulation with heparin and emergent open surgical revascularization.
Soru 1978Soru →

A 32-year-old man comes to the emergency department complaining of right lower quadrant abdominal pain that has been progressively worsening over the past 5 days. He also reports nausea, decreased appetite, and subjective fever. His temperature is 38.8∘C38.8^\circ\text{C} (101.8∘F101.8^\circ\text{F}), blood pressure is 110/70 mmHg110/70\text{ mmHg}, pulse is 105/min105/\text{min}, and respirations are 18/min18/\text{min}. Physical examination reveals focal tenderness and a palpable fullness in the right lower quadrant, with localized guarding. Laboratory studies show a leukocyte count of 18,000/mm318,000/\text{mm}^3 with a left shift. Intravenous fluids and broad-spectrum antibiotics are initiated. A computed tomography scan of the abdomen and pelvis with intravenous contrast reveals a ruptured appendix with an adjacent 6.5-cm6.5\text{-cm} fluid collection demonstrating an enhancing rim. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Percutaneous image-guided drain placement

Cevap

The correct answer is percutaneous image-guided drain placement.
This patient presents with delayed-onset appendicitis complicated by a large (6.5-cm6.5\text{-cm}) periappendiceal abscess. The standard of care for appendicitis complicated by a well-demarcated abscess larger than 3 to 4 cm3\text{ to }4\text{ cm} is initial conservative management with intravenous antibiotics and percutaneous image-guided drainage. This approach allows the severe localized inflammation to subside, significantly reducing the risk of surgical complications such as bowel injury or the need for an extensive bowel resection (e.g., ileocecectomy). An interval appendectomy may be considered several weeks later, though some guidelines suggest it can be omitted if the patient remains asymptomatic.

Adım Adım Çözüm

1
Identify the diagnosis from the clinical presentation and imaging.
The patient has delayed-presentation acute appendicitis complicated by a 6.5-cm6.5\text{-cm} periappendiceal abscess.
Recognizing that this is a complicated appendicitis (perforation with well-formed abscess) rather than early, uncomplicated appendicitis is essential for determining the correct treatment pathway.
2
Determine the standard management guidelines for an appendiceal abscess of this size.
Guidelines recommend initial non-operative management consisting of intravenous antibiotics and percutaneous drainage for abscesses larger than 3 cm3\text{ cm}.
Immediate appendectomy in the setting of severe local inflammation and a large abscess carries a high risk of significant surgical complications, such as iatrogenic bowel injury.
3
Select the corresponding intervention from the options provided.
Percutaneous image-guided drain placement is the definitive next step.
This procedure provides necessary source control while allowing the acute inflammation to subside, potentially followed by an interval appendectomy several weeks later.

Anahtar Kavram

Management of acute appendicitis complicated by a large periappendiceal abscess via percutaneous drainage and intravenous antibiotics.
Soru 1979Soru →

An internal medicine team is evaluating a 67-year-old female who was directly admitted to the hospital with a 24-hour history of high fever, profound weakness, and new-onset gingival bleeding. Her past medical history is notable for seropositive rheumatoid arthritis, essential hypertension, and type 2 diabetes mellitus. Her home medications include weekly oral methotrexate, daily folic acid, lisinopril, and metformin. Review of her recent outpatient records reveals a visit to an urgent care clinic three days prior for dysuria, during which she was prescribed a 7-day course of trimethoprim-sulfamethoxazole.

Upon evaluation, her temperature is 38.2 °C (100.8 °F), blood pressure is 110/70 mmHg, and heart rate is 105/min. Physical examination demonstrates pale conjunctivae and scattered non-blanching petechiae across her lower extremities.

Initial laboratory studies show:

TestResult
Hemoglobin8.4 g/dL
Mean corpuscular volume108 fL
Leukocyte count1,500/mm³
Absolute neutrophil count400/mm³
Platelet count32,000/mm³
Creatinine1.6 mg/dL (baseline 0.9 mg/dL)

Blood and urine cultures have been obtained. Which of the following pharmacologic interventions are immediately indicated for this patient? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Discontinue trimethoprim-sulfamethoxazole; Administer intravenous leucovorin; Initiate intravenous cefepime

Cevap

The correct interventions are to discontinue trimethoprim-sulfamethoxazole, administer intravenous leucovorin, and initiate intravenous cefepime.
The patient is experiencing acute methotrexate toxicity, resulting in severe pancytopenia and acute kidney injury. The correct interventions address both the root cause and the life-threatening complications.

Trimethoprim-sulfamethoxazole must be discontinued as it is the precipitating agent. It interacts with methotrexate by competing for renal tubular secretion and synergistically inhibiting folate synthesis, leading to profound bone marrow suppression.

Intravenous leucovorin (folinic acid) must be administered as it provides a source of active reduced folate that bypasses the inhibited dihydrofolate reductase enzyme, effectively rescuing the bone marrow.

Intravenous cefepime must be initiated because the patient has high-risk febrile neutropenia. With an ANC of 400/mm³ and fever in the setting of acute kidney injury, she requires immediate empiric broad-spectrum intravenous antibiotics with antipseudomonal activity.

Adım Adım Çözüm

1
Identify the primary pathophysiology and the precipitating event.
The patient is experiencing severe pancytopenia and acute kidney injury due to acute methotrexate toxicity. This was triggered by the recent addition of trimethoprim-sulfamethoxazole.
Both trimethoprim and methotrexate inhibit folate metabolism. Additionally, sulfamethoxazole competes with methotrexate for renal tubular secretion, leading to toxic methotrexate accumulation.
2
Determine the immediate antidotal and corrective pharmacologic management for the toxicity.
Discontinue trimethoprim-sulfamethoxazole and administer intravenous leucovorin (folinic acid).
The offending interacting drug must be stopped. Because methotrexate blocks dihydrofolate reductase (DHFR), standard folic acid cannot be activated. Leucovorin is a reduced folate that bypasses DHFR and rescues normal cells.
3
Address the life-threatening infectious complication of the toxicity.
Initiate an intravenous antipseudomonal beta-lactam, such as cefepime.
The patient presents with high-risk febrile neutropenia (ANC of 400/mm³, fever, and end-organ dysfunction via AKI), which mandates immediate broad-spectrum empiric IV antibiotic coverage to prevent rapid progression to septic shock.

Anahtar Kavram

Acute methotrexate toxicity can be precipitated by trimethoprim-sulfamethoxazole, requiring immediate discontinuation of the interacting drug, rescue with leucovorin (which bypasses dihydrofolate reductase), and management of high-risk febrile neutropenia with IV antipseudomonal antibiotics.
Tahmini Süre:2m 0s
Soru 1980Soru →

An emergency medical services unit brings a 36-year-old male to the trauma center following prolonged extraction from a burning residential building. On primary survey, the patient is highly agitated and in severe respiratory distress, demonstrating vigorous accessory muscle use and audible biphasic stridor. His voice is notably hoarse, and there is visible carbonaceous material within the oropharynx. Physical examination reveals leathery, contracted, and painless full-thickness burns circumferentially involving his entire anterior and posterior chest wall, as well as both upper extremities. Vital signs are temperature 37.1°C (98.8°F), heart rate 132/min, blood pressure 88/58 mm Hg, and respiratory rate 36/min. Pulse oximetry shows 91% on a 15 L/min non-rebreather mask. Radial pulses are absent on the left and evaluated only by Doppler ultrasound on the right. His chest excursion is severely limited during maximal inspiratory effort, resulting in shallow tidal volumes. Which of the following procedural interventions are emergently indicated? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: Endotracheal intubation; Bedside escharotomy of the chest and upper extremities

Cevap

The emergently indicated procedural interventions are endotracheal intubation and bedside escharotomy of the chest and upper extremities.
The correct procedural choices directly address the patient's immediate life threats. Stridor and hoarseness in the setting of a house fire indicate supraglottic thermal injury and impending airway obstruction, making endotracheal intubation an immediate necessity. Furthermore, the leathery, circumferential full-thickness burns of the chest act as a tourniquet, severely restricting chest wall expansion and preventing adequate tidal volumes. This restrictive physiology, combined with the loss of distal pulses in the arms, makes bedside escharotomy (incising the burnt tissue to allow expansion) the essential concurrent procedural intervention.

Adım Adım Çözüm

1
Evaluate the patient's airway and breathing status.
The patient exhibits stridor, hoarseness, carbonaceous sputum, and respiratory distress.
These findings indicate upper airway edema from thermal inhalation injury, necessitating immediate endotracheal intubation to secure the airway before complete obstruction occurs.
2
Assess chest wall mechanics and peripheral perfusion.
The patient has circumferential chest burns causing severely limited chest excursion, and circumferential arm burns with absent/weak distal pulses.
Full-thickness thermal burns form an inelastic eschar. On the chest, this creates a restrictive defect preventing ventilation despite intubation. On the extremities, it causes secondary ischemic compromise. Both require emergent bedside escharotomy.

Anahtar Kavram

Immediate procedural management of severe thermal inhalation injury and circumferential full-thickness burns requires rapid airway securement (intubation) and mechanical release of restrictive eschar (escharotomy) to restore ventilation and perfusion.
Tahmini Süre:1m 30s
ÖncekiSayfa 99 / 104Sonraki
Patient Management Alıştırma Soruları — USMLE Step 3 — Sayfa 99 | Examkin